arterial umbilical cord lactate. 47
Specific Aims

30
Maternal oxygen administration for concerning fetal heart rate tracing (FHT) patterns is common practice 31
on Labor and Delivery units in the United States. Despite the broad use of oxygen, it is unclear if this 32 practice is beneficial for the fetus. Category II FHT, as defined by the National Institute of Child Health 33
and Human Development (NICHD), is a broad class of FHT patterns that may suggest cord compression 34 and/or placental insufficiency for which oxygen is most commonly administered. Although some animal 35 and human studies have demonstrated that maternal hyperoxygenation can alleviate such fetal heart rate 36 decelerations, this purported benefit has not been shown to translate into improved fetal outcomes, 37
particularly in relation to acid-base status. In fact, some studies suggest harm with oxygen use due to 38 lower umbilical artery pH and increased delivery room resuscitation or increased free radical activity. 39
Given the indeterminate evidence for this ubiquitously employed resuscitation technique, there is an 40 urgent need to further study the utility of maternal oxygen administration in labor for fetal benefit. 41
We propose a randomized controlled non-inferiority trial comparing oxygen to room air in patients with 42
Category II FHT. Our central hypothesis is that room air alone is not inferior to oxygen administration 43 with regard to neonatal acid-base status and FHT and may in fact, be a safer option for resuscitation due 44
to less production of reactive oxygen species. hypothesis for oxygen benefit and the primary motivation for generalized use in labor is to 87 transfer oxygen to the fetus and therefore improve or reverse the perceived fetal 88 hypooxygenation determined by the FHT.
89
Although some animal and human studies have demonstrated that maternal hyperoxygenation 90 can alleviate fetal heart rate decelerations 4, 5 and increase fetal oxygen saturation 6-9 , this 91 purported benefit has not been shown to translate into improved fetal outcomes, particularly in 92 relation to acid-base status. For example, a study in primates by Morishima et al demonstrated 93 that maternal oxygen administration to those with acidotic hypoxic fetuses elevated fetal oxygen 94 levels and eliminated late decelerations but did not correct acidosis. 10
95
There are a limited number of clinical trials addressing maternal oxygen administration for fetal 96 distress in labor. In 1995, Thorp et al conducted a randomized trial of oxygen versus room air in 97 the second stage of labor, and found no benefit to oxygen exposure and in fact discovered that 98 the oxygen group had a lower umbilical artery pH. This difference was theorized to be a result of women were randomized to oxygen or room air during cesarean delivery. There was no 104 difference in umbilical artery pH between groups, however the oxygen exposed group had 105 increased free radical activity in cord blood samples 8 . Studies such as these have prompted 106 questioning of both the safety and the efficacy of oxygen for Category II FHT and highlight the 107 urgent need for further investigation, particularly given its wide-spread use.
108
The primary objective of this study is to evaluate whether oxygen for intrauterine fetal 109 resuscitation of Category II FHT affects fetal metabolic acid-base status as determined by 110 umbilical cord lactate values. Secondary objectives include analysis of additional cord gas 111 parameters used to predict neonatal wellbeing, changes to FHT patterns, and cord blood and 112 maternal MDA as a marker of free radical activity. We hypothesize that room air exposure for 113 Category II FHT in labor is no different from maternal oxygen administration with regard to fetal 114 acid-base status. The theorized benefit of maternal oxygen administration is increase oxygen 124 delivery to the fetus via the umbilical cord vein ( Figure 1 ) resulting in 125 prevention or reversal of anaerobic metabolism and a subsequent 126 reflection in umbilical cord artery findings. This, however, has not been 127 substantiated by evidence thus far. We hypothesize that room air, as a 128 substitute for oxygen supplementation, is no different than oxygen in 129 altering the acid-base status of the neonate as reflected in umbilical 130 cord gas parameters. Secondary outcomes will be additional 131 components of an umbilical artery gas. In clinical practice, oxygen is administered to patients with Category II FHT in order to 135 resuscitate potential fetal hypooxygenation that manifests as heart rate decelerations. Evidence 136 thus far shows that Category II FHT are associated with a wide spectrum of neonatal outcomes 137 and therefore do not uniformly reflect fetal acid-base status 19, 20 . Hence, evaluating the effect of 138 oxygen on subsequent FHT categorization is pivotal to labor management. The outcome that will 139 be investigated is rate of persistent Category II FHT after intervention. We will also evaluate the 140 types and frequency of deceleration patterns present both pre and post intervention. We 141 hypothesize that oxygen administration for Category II FHT will be associated with a rate of 142 persistent Category II FHT that is not different from those exposed to room air. Prior studies have evaluated the relationship between maternal oxygen administration in labor 166 and markers of free radical formation 8, 12 with mixed results. We hypothesize that maternal 167 hyperoxygenation for Category II FHT is associated with increased oxidative stress in the mother 168 and fetus. We will measure MDA in maternal and neonatal cord blood samples as a gage for 169 oxidative stress and to assess the relationship between oxygen administration and subsequent 170 free radical formation. The aim of this study is to compare maternal oxygen administration to room air for intrauterine 192 resuscitation of Category II FHT in relation to cord gas parameters, FHT patterns, and oxidative 193 stress in the fetus and mother. The study will be a prospective, randomized non inferiority trial to 194 be conducted at Barnes Jewish Hospital. Current practice at our institution for intrauterine fetal 195 resuscitation of Category II FHT include any of the combination of (1) oxygen administration via 196 nonrebreather face mask at 10L/min (FiO2 approximately 0.80) 36 continued for the duration of 197 labor (2) intravenous fluid bolus (3) maternal repositioning (4) discontinuation of oxytocin. We 198 hypothesize that room air for Category II FHT will be no different than oxygen administration in 199 reducing the degree of fetal metabolic acidosis. This study will include term, singleton patients (Figure 3 ). This will be 212 performed via a computer-generated randomization sequence in a 1:1 ratio. Patients randomized 213 to the oxygen group will receive the above stated current management of oxygen via 214 nonrebreather face mask at 10L/min and "per-protocol" defined as receiving the mask for at least 215 90% of the remaining duration of labor including during cesarean delivery. Patients randomized 216 to the room air group will not receive oxygen for Category II FHT unless otherwise required for 217 maternal indications. Alternative and/or additional intrauterine resuscitation techniques for both 218 groups (i.e. fluid bolus, maternal repositioning, and discontinuation of oxytocin) will be left to the discretion of the medical team. The initial 6 patients consented and randomized will be part 220 of a compliance run-in with the same protocol as above. We will be measuring serum MDA in both cord and maternal blood as a marker of oxidative 238 stress. MDA is a byproduct of lipid peroxidation, which occurs as a result of oxidative stress.
239
Measurement of Thiobarbituric Acid Reactive Substances (TBARS) is a commonly used assay Upon delivery of the infant, an additional sample of umbilical artery blood will be collected for 243 this analysis. An optional sample of maternal blood will also be drawn within 60 minutes of 244 delivery. Both blood samples will be centrifuged to collect plasma which will then be stored at -245 80•C until the TBARS assay is performed. A review of previously collected data from our institution of 5182 term singleton pregnancies 322 revealed a mean cord lactate of 3.5±1.6 mmol/L in women with Category II FHT within 30 323 minutes of delivery. All of these deliveries were managed using our current protocol of routine 324 oxygen administration for Category II FHT. Given the normal mean lactate seen in our 325 population of patients with Category II FHT, a noninferiority approach was selected to test our 326 hypothesis that room air is not inferior to oxygen administration in treating Category II FHT. A 327 total sample size of 98 patients will be needed to detect a non-inferiority margin of 30% with 328 90% power, using a one-sided two-sample t-test (alpha 0.025). To accommodate a 15% drop 329 out/cross over rate, a total of 114 patients will be needed. We plan on performing an initial 330 compliance run-in of 6 patients making the total enrollment 120 patients. Data analysis will only 331 be performed on the 114 patients enrolled after the initial 6 patients enrolled/randomized in the 332 compliance run-in/pilot. Previous studies have shown an increased risk for neonatal morbidity 333 with cord lactate cut-offs ranging from 3.2-6.0 14, 15, [38] [39] [40] [41] . The margin of noninferiority was 334 therefore set at a lactate cut-off of 4.5, above which there is a clear association with neonatal 335 morbidity. 
